CIN16645
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 555767

CAS#: 1799316-64-5 (free base)

Description: CIN16645, also known as LP-01 lipid, is an ionizable lipid, IT is useful in lipid nanopparticle formulation for DNA and RNA vaccine delivery and Gene editing. CIN16645 was first reported in Novartis patent WO 2015095340A1. This product has no formal name at the moment. For the convenience of communication, a temporal code name was therefore proposed according to MedKoo Chemical Nomenclature (see web page: https://www.medkoo.com/page/naming)..


Chemical Structure

img
CIN16645
CAS# 1799316-64-5 (free base)

Theoretical Analysis

MedKoo Cat#: 555767
Name: CIN16645
CAS#: 1799316-64-5 (free base)
Chemical Formula: C50H93NO9
Exact Mass: 851.69
Molecular Weight: 852.292
Elemental Analysis: C, 70.46; H, 11.00; N, 1.64; O, 16.89

Price and Availability

Size Price Availability Quantity
5mg USD 150 Ready to ship
10mg USD 250 Ready to ship
25mg USD 450 Ready to ship
50mg USD 750 Ready to ship
100mg USD 1250 Ready to ship
200mg USD 1950 Ready to ship
Bulk inquiry

Related CAS #: CIN16645 HCl   1799316-64-5 (free base)  

Synonym: CIN-16645; CIN 16645; CIN16645; LP-01 lipid;

IUPAC/Chemical Name: 3-((4,4-bis(octyloxy)butanoyl)oxy)-2-((((3-(diethylamino)propoxy)carbonyl)oxy)methyl)propyl (9Z,12Z)-octadeca-9,12-dienoate

InChi Key: CHTXXFZHKGGQGX-IFLFXUNCSA-N

InChi Code: InChI=1S/C50H93NO9/c1-6-11-14-17-20-21-22-23-24-25-26-27-28-29-32-36-47(52)58-43-46(45-60-50(54)57-42-35-39-51(9-4)10-5)44-59-48(53)37-38-49(55-40-33-30-18-15-12-7-2)56-41-34-31-19-16-13-8-3/h20-21,23-24,46,49H,6-19,22,25-45H2,1-5H3/b21-20-,24-23-

SMILES Code: CCCCC/C=C\C/C=C\CCCCCCCC(OCC(COC(OCCCN(CC)CC)=O)COC(CCC(OCCCCCCCC)OCCCCCCCC)=O)=O

Appearance: Oily Liquid (Lipid)

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target: CIN-16645 is a cationic lipid and is useful in the delivery of biologically active agents to cells and tissues.
In vitro activity: TBD
In vivo activity: TBD

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
Soluble in DMSO 0.0 0.00

Preparing Stock Solutions

The following data is based on the product molecular weight 852.29 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol: TBD
In vitro protocol: TBD
In vivo protocol: TBD

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1. Brito, Luis; Chen, Delai; Gamber, Gabriel Grant; Geall, Andrew; Love, Kevin; Zabawa, Thomas; Zecri, Frederic (Novartis AG, Switz.). WO2015095340A1

2. Morrissey, David V.; Patel, Mihir Chandrakant; Finn, Jonathan D.; Smith, Amy Madison Rhoden; Shaw, Lucinda J.; Dombrowski, Christian; Shah, Ruchi Rudraprasad (Assignee: Intellia Therapeutics, Inc., USA), Lipid nanoparticle formulations for CRISPR​/Cas components, WO 2017173054.